Delivery Order SPE2DB22D2211-SPE2DB24FMLN2
Award Date 12/26/23
Potential Completion Date 12/27/23
Potential Value $54K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $9,151.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract for the supply of BUPROPION HCL XL 300 MG TABLET 500S, with a completion date of February 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $34,961.14, is for the delivery of Bupropion HCL XL 300 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract was awarded on February 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,698.91 for the provision of 4,562,939,577 units of Bupropion HCL XL 300 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of November 30, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Bupropion HCL XL 300 mg tablets to support military healthcare programs. The $2,958.69 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distributor serving federal government agencies. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,045.17 for the supply of 4555741119 - Bupropion HCL XL 150 mg tablets. The award was made by the Defense Logistics Agency (DLA), which is a defense agency under the Department of Defense (DoD). The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $13,869.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets in quantities of 500 tablets per bottle. This is a Firm Fixed Price Delivery Order contract with a completion date of February 8, 2024. The contract was awarded on February 7, 2024 and does not have a set-aside designation, indicating open...
- This federal contract award, valued at $2,513.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562677107 - BUPROPION HCL XL 300 MG TABLET 90S, with a completion date of November 2, 2023. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $51,618.39, is for the delivery of 4,564,448,914 units of Bupropion HCL XL 150 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of May 1, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $76,155.70, is a firm fixed price delivery order for the supply of Bupropion HCL XL 300 mg tablets. The award does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...